BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Endothelial cell
,
Amniocentesis
,
Prozac
,
rs2476601
,
MDM2
,
Apoptosis
,
Influenza
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
rep 1
Summary
General Info
Curated Studies
Most Correlated Studies
Gene expression in loss-of-function mutations in REP-1 in fibroblasts and monocytes
Prostate stromal WPMY1 cells grown in complete or androgens-deprived media with or without Olaparib
iPSC gene expression in response to culture with a small molecule inhibitor cocktail
Breast cancer MCF7 cells treated with 102 traditional Chinese medicinal components
Pancreatic carcinoma cells with SREBP2 siRNA grown in culture media at normal or low acidic pH
Explore Curated Studies Results
Literature
Most Relevant Literature
Loss of REP1 impacts choroidal melanogenesis and vasculogenesis in choroideremia.
Molecular Characterization of Choroideremia-Associated Deletions Reveals an Unexpected Regulation of…
CHML is an NRF2 target gene that regulates mTOR function.
Gene Augmentation of CHM Using Non-Viral Episomal Vectors in Models of Choroideremia.
Choroideremia: molecular mechanisms and therapies.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients
Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients
REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection
Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B
REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infection
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ